78 results
Page 3 of 4
424B5
xoufw0axw1 ynqoelr
9 Jan 20
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
foq5fd 5xrs
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
424B5
kd19b3iuubli0wx 9wj
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
EX-4.3
4oonl w53qn0atpy8ttj
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
9l2mj7xza8c8mvf7a2
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
888em4u wkwn
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
8mqru kkojzmfe
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
9nph74k
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
POS AM
pi4x8xdj0od iytyg8z
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-4.1
eh9szs
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm
424B5
qgmpegfc60bwn41
7 Mar 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
j54r7
7 Mar 19
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:15pm
424B5
be0a3o1war0kb
6 Mar 19
Prospectus supplement for primary offering
4:07pm
POS AM
70p9li tzj6dypcl
26 Feb 19
Prospectus update (post-effective amendment)
4:47pm